Promoted Content
Promoted Content

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Loading...

All Data

Filters Filter refresh
×
FILTER DATA :
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter
            refresh

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): EI1071

            Therapeutic Area: Neurology Product Name: EI1071

            Highest Development Status: Phase I Product Type: Small molecule

            Partner/Sponsor/Collaborator: Alzheimer's Association

            Deal Size: $1.0 million Upfront Cash: Undisclosed

            Deal Type: Funding August 26, 2020

            Details:

            Grant Program will support a U.S. FDA-approved first-in-human phase 1 clinical trial of its lead drug candidate, EI1071, an orally available, highly potent Colony-Stimulating Factor 1 Receptor (CSF1R) inhibitor.